It has previously been observed that with methohexitone and propanidid the incidence and severity of induction side effects increases with increase in dosage. A mixture containing methohexitone 10 mg and propanidid 25 mg per ml was used as main anaesthetic agent with nitrous oxide-oxygen for a standard operative procedure in adult females. It was anticipated that the mixture would be followed by fewer side effects than comparable doses of propanidid and methohexitone alone. This hope was fulfilled and it proved to be a satisfactory induction agent. Dosage studies showed that there was some loss of potency, which is more likely to have affected the propanidid component in view of the pH of the mixture (10.15). It became more acid on storage over six weeks and there was further detectable loss of potency. It is recommended that methohexitone-propanidid mixtures should only be used when freshly prepared.
It has previously been observed that with methohexitone and propanidid the incidence and severity of induction side effects increases with increase in dosage. A mixture containing methohexitone 10 mg and propanidid 25 mg per ml was used as main anaesthetic agent with nitrous oxide-oxygen for a standard operative procedure in adult females. It was anticipated that the mixture would be followed by fewer side effects than comparable doses of propanidid and methohexitone alone. This hope was fulfilled and it proved to be a satisfactory induction agent. Dosage studies showed that there was some loss of potency, which is more likely to have affected the propanidid component in view of the pH of the mixture (10.15). It became more acid on storage over six weeks and there was further detectable loss of potency. It is recommended that methohexitone-propanidid mixtures should only be used when freshly prepared.
The scope of intravenous anaesthesia has been increased in recent years by the availability of drugs with a shorter duration of action than thiopentone, particularly methohexitone (Brietal) and propanidid (Epontol). They do, however, have drawbacks. Methohexitone is frequently followed by spontaneous involuntary muscle movement and hiccough, and its administration may be followed by a hangover. The duration of action of propanidid is very short. Many anaesthetists therefore find difficulty in avoiding the return of the state of the patient to consciousness before an adequate concentration of an inhalation agent can be achieved. Solutions of propanidid are inconveniently viscid.
The incidence of side effects following the administration of intravenous anaesthetics increases with dosage (Barron and Dundee, 1967) , an effect which also applies to propanidid. It therefore occurred to us to use a solution, which in fact proved to be less viscid than ordinary propanidid, of equal volumes of 2 per cent methohexitone and 5 per cent propanidid (M-P). It was hoped that the anaesthetic effects would be additive but since the side effects of the two agents are not identical, the incidence of complications during induction would be much lower. It has already been indicated in general terms that this is so (Dundee et al., 1967) .
METHOD

The solution.
Freshly prepared solution, containing methohexitone 10 mg/ml and propanidid 25 mg/ml, has a pH of 10.15. This is slightly less alkaline than 1 per cent methohexitone whose pH is 10.85 and very much less acid than propanidid which in a 2.5 per cent solution has a pH of 5.2. The methohexitone-propanidid solution becomes increasingly acid on storage at room temperature ( fig. 1 ) and may become cloudy at the end of one week. If stored at 4°C solutions will certainly remain clear until the end of the second week and, on occasions, have remained satisfactory for six weeks.
The solution used in this study was prepared by adding 25 ml of water and 25 ml of 5 per cent propanidid to 500 mg of methohexitone powder. Half the 100 patients studied received the freshly prepared solution. The other half were anaesthetized with a clear mixture which had been stored for 3-5 weeks either at 4°C or 20°C As there was no difference in the incidence of complications between the two groups the data for the two were pooled. 
Patients and operation.
This mixture was considered to be equipotent (v/v) with 2 per cent methohexitone or 5 per cent propanidid. It was used as the main anaesthetic for a standard operation, being given immediately before nitrous oxide and oxygen for minor gynaecological procedures. The initial dose was 0.08 ml/kg (0.5 ml/stone), a 70 kg (11 stone) patient receiving 137 mg propanidid and 55 mg methohexitone. Details of the observations made during and after anaesthesia have been described elsewhere (Dundee, Moore and Nicholl, 1962; Dundee and Clarke, 1964) . These patients were broadly comparable with respect to age and body weight with 300 patients who had previously been given methohexitone and 200 who had received propanidid in a previous investigation (Dundee and Clarke, 1964) . Table I lists the complications occurring during anaesthesia and the condition of the patients at the end of the operation. The incidence of excitatory phenomena and hiccough was lower than in V=Vomiting (including retching). N = Nausea. When vomiting and nausea both occurred, it is recorded as V. * Data from previous investigation (Dundee and Clarke, 1964) included for comparison.
RESULTS
patients given methohexitone and approximated Dosage and potency. to that in patients given propanidid. Hypotension
In order to establish that the operation could exceeding 20 mm Hg occurred in only one not have been carried out with only the dose of patient. The number of patients who were awake methohexitone in the mixture, 25 patients were within 2 minutes of the end of the operation was anaesthetized with this amount of barbiturate smaller than in the methohexitone or propanidid (0.8 mg/kg). In these cases supplementary doses series. The incidence of emetic sequels was less were required very soon and in fact the mean with the mixture than with either of the drugs total dose of methohexitone was substantially the alone (table II) . This may be partly due to the same as that required by patients given double delayed recovery.
this amount of methohexitone for induction (table The overall course of anaesthesia, as judged by HI)-(A similar study was not carried out with the grading system of Dundee, Moore and Nicholl propanidid as doses of 2.0 mg/kg do not always (1962) , indicates that methohexitone is less satis-produce unconsciousness.) Thus it is clearly factory than either of the other compounds (fig. established that both components in the mixture 2). The quality of anaesthesia with the mixture contribute to the subsequent anaesthesia, was comparable with that obtained with thio-
The cumulative effects of methohexitone ; propentone (Dundee and Clarke, 1964) .
panidid and the methohexitone-propanidid mix- ture were compared (table III) using the average ratio of total to induction dose required for the standard operation. Had each agent contributed equally to the anaesthesia the ratio for the mixture would have fallen between that for each of its constituents, whereas it is significantly higher than that for propanidid (P<0.025) which in turn is less cumulative than methohexitone. This can be most easily explained by a breakdown of one or other, or even both, constituents of the mixture; when the ratios are calculated for freshly prepared and stored mixtures the latter would appear to be inactivated to the greater degree. On the basis of these ratios the methohexitone-propanidid mixture has lost about one-quarter of its potency. The approximate figures are 17 per cent for the fresh and 32 per cent for the stored mixture. Considering the physical characteristics of the drugs, propanidid is more likely than methohexitone to be inactivated in an alkaline mixture. In a 1 per cent solution the latter will not precipitate into free acid until the pH falls to 9.3. Assuming that only propanidid is inactivated, the extent of this breakdown can be calculated from the total dose requirements shown in table HI. The differences in average duration of anaesthesia in the three series are ignored and a ratio of relative potency of methohexitone to propanidid has been agreed as being between 2.5:1 (ratio of induction doses) and 3:1 (ratio of total doses). The difference between the average dose of methohexitone when used alone and that contained in the mixture must be accounted for by the propanidid in the mixture. On this basis one can calculate (see Appendix) the possible loss of potency of propanidid in the mixture as follows:
Freshly prepared mixture 28-48 per cent Stored mixture 47-73 per cent Pooled data 38-56 per cent
DISCUSSION
The original suggestion that the use of a mixture of methohexitone and propanidid would result in a lower incidence of side effects than methohexitone alone has been amply confirmed. Such a mixture would therefore have something to offer for induction of anaesthesia. The fact that fewer patients were awake within 2 minutes of the end of surgery gives a misleading impression of the brevity of action of the methohexitone-propanidid mixture. Studies now being undertaken indicate that the duration of its action is intermediate between that of its constituents. This eliminates the difficulty of too quick recovery following the administration of propanidid. The loss of potency shown in the data in table HI was unexpected because this had not been detected clinically (Dundee et al., 1967) . In a circular letter sent to anaesthetists, the manufacturers of both methohexitone and propanidid drew attention to the possible breakdown of the latter drug in intensely alkaline solution. The present study, however, shows that the mixture is clinically acceptable and avoids some of the disadvantages of its constituents when used alone. In view of the fall in pH on storage, however, and the loss of potency it is recommended that only freshly prepared solutions be used and that under no circumstances should a solution in which a precipitate forms be injected.
APPENDIX
Calculations of possible loss of potency of propanidid (P) in the methohexitone-propanidid mixture (M-P).
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